{"database": "lobbying", "table": "lobbying_activities", "rows": [[2181938, "42629887-8f5d-4168-a84d-70bba16a0156", "Q3", "BROWN RUDNICK LLP", 287895, "PRIME THERAPEUTICS", 2018, "third_quarter", "PHA", "S. 2554-Patient Right to Know Drug Prices Act; H.R. 5343-Prescription Transparency Act of 2018.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2018-10-10T13:27:42.463000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2181938"], "units": {}, "query_ms": 22.50750601524487, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}